Literature DB >> 8803357

Recent developments in the pharmacotherapy of substance abuse.

C P O'Brien1.   

Abstract

Modern concepts of addictive disorders emphasize the compulsive and relapsing drug-taking behaviors rather than tolerance and physical dependence. As with any chronic disorder, long-term treatment is necessary and medications may aid in the rehabilitative process. Specific medications have been demonstrated to be helpful for psychiatric disorders coexisting with addiction. Medications have also been demonstrated in controlled studies to aid in the rehabilitation of patients dependent on nicotine, alcohol, or opiates. Thus far, no medication has been clearly demonstrated to benefit patients suffering from abuse or dependence on cocaine, cannabinoids, nonalcohol sedatives, or hallucinogens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803357     DOI: 10.1037//0022-006x.64.4.677

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  11 in total

1.  Effects of olfactory stimuli on urge reduction in smokers.

Authors:  M A Sayette; D J Parrott
Journal:  Exp Clin Psychopharmacol       Date:  1999-05       Impact factor: 3.157

2.  The developmental impact of two first grade preventive interventions on aggressive/disruptive behavior in childhood and adolescence: an application of latent transition growth mixture modeling.

Authors:  Hanno Petras; Katherine Masyn; Nick Ialongo
Journal:  Prev Sci       Date:  2011-09

Review 3.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

Review 4.  AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future.

Authors:  M Scott Bowers; Billy T Chen; Antonello Bonci
Journal:  Neuron       Date:  2010-07-15       Impact factor: 17.173

Review 5.  Activators of G-protein signaling 3: a drug addiction molecular gateway.

Authors:  Michael Scott Bowers
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

6.  Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.

Authors:  Giordano de Guglielmo; Marsida Kallupi; Giulia Scuppa; Gregory Demopulos; George Gaitanaris; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2016-10-06       Impact factor: 4.530

7.  Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Drake Morgan; Mark A Smith; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

8.  Gene expression changes in the medial prefrontal cortex and nucleus accumbens following abstinence from cocaine self-administration.

Authors:  Willard M Freeman; Melinda E Lull; Kruti M Patel; Robert M Brucklacher; Drake Morgan; David C S Roberts; Kent E Vrana
Journal:  BMC Neurosci       Date:  2010-02-26       Impact factor: 3.288

9.  Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration.

Authors:  Willard M Freeman; Kruti M Patel; Robert M Brucklacher; Malinda E Lull; Mandi Erwin; Drake Morgan; David C S Roberts; Kent E Vrana
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

10.  Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat.

Authors:  Shane A Perrine; Imran S Sheikh; Chinwe A Nwaneshiudu; Joseph A Schroeder; Ellen M Unterwald
Journal:  Neuropharmacology       Date:  2007-10-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.